Supernus Pharma (SUPN) Reports Q4 Revenue of $155M

Go back to Supernus Pharma (SUPN) Reports Q4 Revenue of $155M
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 43.75 +0.97 (2.27%)
Previous Close $42.78    52 Week High $26.84 
Open $43.04    52 Week Low $9.51 
Day High $44.25    P/E N/A 
Day Low $42.82    EPS $-2.62 
Volume 667,587